HTBA will present Leanara alongside its wider portfolio of nature-led, science-backed flavonoids and active B12 solutions at Vitafoods Europe, 5–7 May in Barcelona.

“Interest in GLP‑1 weight loss therapies is already booming in the USA, and the ripple effect is reaching Europe now too, with an estimated 4.9 million British adults having recently used or expressed interest in GLP-1 medications,“ comments Tom D’Hoore, Chief Commercial Officer at HTBA. While these therapies can deliver significant reductions in body weight, research suggests that 40–60% of this loss may come from lean muscle mass if not actively managed. This is where functional foods and supplements can play a key role, helping GLP-1 users maintain strength and vitality throughout their weight loss journey.”

To address this growing need, HTBA has developed Leanara, a dual effect companion ingredient that combines proprietary bioflavonoids with highly bioavailable vitamin B12 to support lean muscle development and reduce fatigue, all while optimizing metabolism. For brands, this represents an exciting opportunity to explore new GLP-1 companion supplement formulations that go beyond weight loss to deliver sustainable health outcomes.

HTBA will further spotlight the market opportunity at Vitafoods Europe in its presentation, “Beyond weight loss: protect lean muscle and energy for GLP-1 users,” taking place on Tuesday, 5 May, from 4:00 PM to 4:25 PM at the New Ingredients Theatre (3D258). Dr Teresa Pellicer, Biotechnology Manager at HTBA, will explore the physiological challenges associated with GLP-1 use and explain the science behind Leanara, showing how targeted nutritional support can help preserve muscle integrity, reduce fatigue and maintain metabolic health during weight loss journeys.

Photo: HTBA